Related Experiment Videos

Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles

P Devaux1, D Gerlier

  • 1Immunité et Infections Virales, IVMC, CNRS-UCBL UMR 5537, Faculté de Médecine Lyon RTH Laënnec, France.

Journal of Virology
|February 1, 1997
PubMed

Insights

Antimoesin antibodies bind to cells expressing CD46, inhibiting measles virus entry. This binding is due to cross-reactivity with CD46, not direct interaction with moesin.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • CD46 is a cell surface receptor involved in immune regulation and serves as a receptor for measles virus (MV).
  • Moesin is a protein involved in cell structure and signaling, and its potential role in MV entry has been investigated.

Purpose of the Study:

  • To investigate the interaction between antimoesin antibodies, CD46, and measles virus entry.
  • To determine if moesin is directly involved in measles virus binding to CD46.

Main Methods:

  • Cell surface binding assays using antimoesin antibodies and human/rodent cells with varying CD46 expression levels.
  • Western blot analysis of antimoesin antibody reactivity with purified CD46 and CD46 domains.
  • Testing the effect of antimoesin antibodies on measles virus entry.

Main Results:

  • Antimoesin antibodies from ascites fluids bound to cells in parallel with CD46 expression.
  • Purified antimoesin antibodies recognizing intracellular moesin did not show cell surface reactivity.
  • Antimoesin antibodies reacted with solubilized CD46 and CD46 domains essential for MV binding.
  • These antibodies showed weak cross-reactivity with CD46, explaining their inhibitory effect on MV entry.

Conclusions:

  • The inhibitory effect of antimoesin antibodies on measles virus entry is attributed to their weak cross-reactivity with CD46.
  • Moesin is not directly involved in the binding of measles virus to CD46.

Related Concept Videos